322
Views
2
CrossRef citations to date
0
Altmetric
Invited Reviews

The Historical Evolution of Ocular Tuberculosis: Past, Present, and Future

, MBBSORCID Icon, , MBBSORCID Icon, , MDORCID Icon, , FRANZCOORCID Icon, , FRANZCOORCID Icon, , MDORCID Icon, , FRCOphthORCID Icon, , MDORCID Icon & , MDORCID Icon show all
Pages 593-599 | Received 11 Jun 2021, Accepted 06 Oct 2021, Published online: 09 Nov 2021

References

  • Riccardi N, Canetti D, Martini M, et al. The evolution of a neglected disease: tuberculosis discoveries in the centuries. J Prev Med Hyg. 2020;61(1 Suppl 1):E9–E12. doi:10.15167/2421-4248/jpmh2020.61.1s1.1353. [published Online First: Epub Date]|.
  • Waksman SA. The Conquest of Tuberculosis. University of California Press; 1964.
  • Koch R. The etiology of tuberculosis. Berl Klin Wochenschr. 1882;15:221–230.
  • Maître-Jan A. Traite des maladies des yeux. Troyes: Jacques le Febvre. 1711;1707.
  • Jaeger E. Ueber Choroidealtuberkel. Oesterr Ztschr Pract Heilk. 1855;1:9–10.
  • Manz W. Tuberculose der Chorioidea. Archiv für Ophthalmologie. 1858;4(2):120–126.
  • Cohnheim J. Ueber tuberculose der chorioidea. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin. 1867;39(1):49–69.
  • Gradenigo P, Jeffries BJ. Tuberculosis of the iris. Boston Med Surg J. 1869;81(20–21):285–287. doi:10.1056/NEJM186911250812001.
  • Zur PM. Kenntniss der Tuberculose des Auges. Albrecht von Graefes Archiv für Ophthalmologie. 1873;19(1):221–246. doi:10.1007/BF01694023.
  • Von Michel J. Über iris und iritis. Albrecht v Grafes Arch Ophthalmol. 1883;27:171–282. doi:10.1007/BF01693194.
  • Murray JF. A century of tuberculosis. Am J Respir Crit Care Med. 2004;169(11):1181–1186. doi:10.1164/rccm.200402-140OE. [published Online First: Epub Date]|.
  • Guyton JS, Woods AC. Etiology of uveitis: a clinical study of 562 cases. Arch Ophthalmol. 1941;26(6):983–1018. doi:10.1001/archopht.1941.00870180061004.
  • Billings F. Focal infection: its broader application in the etiology of general disease. JAMA. 1914;63(11):899–903. doi:10.1001/jama.1914.02570110001001.
  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis–an update. Surv Ophthalmol. 2007;52(6):561–587. doi:10.1016/j.survophthal.2007.08.015. [published Online First: Epub Date]|.
  • Testi I, Agrawal R, Mahajan S, et al. Tubercular uveitis: nuggets from collaborative ocular tuberculosis study (COTS)-1. Ocul Immunol Inflamm. [published Online First: Epub Date]|. 2019:1–9. doi:10.1080/09273948.2019.1646774.
  • Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1. JAMA Ophthalmol. 2017;135(12):1318–1327. doi:10.1001/jamaophthalmol.2017.4485. [published Online First: Epub Date]|.
  • Woods AC. Modern concepts of the etiology of uveitis. Am J Ophthalmol. 1960;50:1170–1187. doi:10.1016/0002-9394(60)91006-0.
  • Patel SS, Saraiya NV, Tessler HH, Goldstein DA. Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity. JAMA Ophthalmol. 2013;131(6):752–758. doi:10.1001/jamaophthalmol.2013.71. [published Online First: Epub Date]|.
  • Virchow R. Remarks on the effect of Koch’s remedy on the internal organs of tuberculous patients. Br Med J. 1891;1(1568):127–132. doi:10.1136/bmj.1.1568.127. [published Online First: Epub Date]|.
  • Donahue HC. Ophthalmologic experience in a tuberculosis sanatorium. Am J Ophthalmol. 1967;64(4):742–748. doi:10.1016/0002-9394(67)92860-7. [publishedOnline First: Epub Date]|.
  • Murray JF, Schraufnagel DE, Hopewell PC. Treatment of tuberculosis. A historical perspective. Ann Am Thorac Soc. 2015;12(12):1749–1759. doi:10.1513/AnnalsATS.201509-632PS. [published Online First: Epub Date]|.
  • Iseman MD. Tuberculosis therapy: past, present and future. Eur Respir J Suppl 2002;36:87s–94s doi: 10.1183/09031936.02.00309102. [published Online First: Epub Date]|.
  • Davis A. A historical perspective on tuberculosis and its control. Lung Biol Health Dis. 2000;144:3–54.
  • Holmberg SD. The rise of tuberculosis in America before 1820. Am Rev Respir Dis. 1990;142(5):1228–1232. doi:10.1164/ajrccm/142.5.1228.
  • Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55(3):173–183. doi:10.4103/0301-4738.31936. [published Online First: Epub Date]|.
  • Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol. 2004;52:121–125.
  • Islam SM, Tabbara KF. Causes of uveitis at The Eye Center in Saudi Arabia: a retrospective review. Ophthalmic Epidemiol. 2002;9(4):239–249. doi:10.1076/opep.9.4.239.1507. [published Online First: Epub Date]|.
  • Al Dhahri H, Al Rubaie K, Hemachandran S, et al. Patterns of uveitis in a university-based tertiary referral center in Riyadh, Saudi Arabia. Ocul Immunol Inflamm. 2015;23(4):311–319. doi:10.3109/09273948.2014.939197. Epub 2014 Jul 24.[published Online First: Epub Date]|.
  • Abu El-Asrar AM, Al-Mezaine HS. Anti-tuberculous therapy combined with systemic corticosteroids improves retinal sensitivity in patients with active presumed tuberculous choroiditis. Int Ophthalmol. 2010;30(5):567–576. doi:10.1007/s10792-010-9371-2. Epub 2010 May 15.[published Online First: Epub Date]|.
  • Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11(4):277–286. doi:10.1076/ocii.11.4.277.18260. [published Online First: Epub Date]|.
  • Merrill PT, Kim J, Cox TA, Betor CC, McCallum RM, Jaffe GJ. Uveitis in the southeastern United States. Curr Eye Res. 1997;16(9):865–874. doi:10.1076/ceyr.16.9.865.5048. [published Online First: Epub Date]|.
  • Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114(5):593–599. doi:10.1001/archopht.1996.01100130585016. [published Online First: Epub Date]|.
  • Cimino L, Herbort CP, Aldigeri R, Salvarani C, Boiardi L. Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol. 2009;29(2):67–74. doi:10.1007/s10792-007-9071-8. Epub 2007 May 8.[published Online First: Epub Date]|.
  • Sanghvi C, Bell C, Woodhead M, Hardy C, Jones N. Presumed tuberculous uveitis: diagnosis, management, and outcome. Eye (Lond). 2011;25(4):475–480. doi:10.1038/eye.2010.235. Epub 2011 Feb 4.[published Online First: Epub Date]|.
  • Shirley K, Dowlut S, Silvestri J, Pavesio C, Foot B. Presumed ocular tuberculosis in the United Kingdom: a British Ophthalmological Surveillance Unit (BOSU) study. Eye (Lond). 2020;34:1835–1841. doi:10.1038/s41433-019-0748-9.
  • Gupta A, Bansal R, Gupta V, Sharma A, Bambery P. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010;149(4):562–570. doi:10.1016/j.ajo.2009.11.020. Epub 2010 Feb 10.[published Online First: Epub Date]|.
  • Agrawal R, Gunasekeran DV, Raje D, et al. Global variations and challenges with tubercular uveitis in the collaborative ocular tuberculosis study. Invest Ophthalmol Vis Sci. 2018;59(10):4162–4171. doi:10.1167/iovs.18-24102. [published Online First: Epub Date]|.
  • Basu S, Monira S, Modi RR, et al. Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis. J Ophthalmic Inflamm Infect. 2014;4(1):3. doi:10.1186/1869-5760-4-3. [published Online First: Epub Date]|.
  • Tognon MS, Fiscon M, Mirabelli P, et al. Tuberculosis of the eye in Italy: a forgotten extrapulmonary localization. Infection. 2014;42(2):335–342. doi:10.1007/s15010-013-0554-4. Epub 2013 Nov 26.[published Online First: Epub Date]|.
  • Ang M, Htoon HM, Chee SP. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology. 2009;116(7):1391–1396. doi:10.1016/j.ophtha.2009.02.005. [published Online First: Epub Date]|.
  • Al-Mezaine HS, Al-Muammar A, Kangave D, Abu El-Asrar AM. Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis. Int Ophthalmol. 2008;28(6):413–423. doi:10.1007/s10792-007-9170-6. Epub 2007 Nov 22.[published Online First: Epub Date]|.
  • Urzua Ca, Lantigua Y, Abuauad S, et al. Clinical features and prognostic factors in presumed ocular tuberculosis. Curr Eye Res. 2017;42(7):1029–1034. doi:10.1080/02713683.2016.1266663. Epub 2017 Feb 3.[published Online First: Epub Date]|.
  • Jakob E, Max R, Zimmermann S, et al. Three years of experience with QuantiFERON-TB gold testing in patients with uveitis. Ocul Immunol Inflamm. 2014;22(6):478–484. doi:10.3109/09273948.2013.866255. Epub 2014 Jan 10.[published Online First: Epub Date]|.
  • Agrawal R, Agarwal A, Jabs DA, et al. Standardization of nomenclature for ocular tuberculosis - results of collaborative ocular tuberculosis study (COTS) workshop. Ocul Immunol Inflamm. [published Online First: Epub Date]|. 2019:1–11. doi:10.1080/09273948.2019.1653933.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057. [published Online First: Epub Date]|.
  • de Parisot A, Kodjikian L, Errera MH, et al. Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ULISSE). Am J Ophthalmol. 2017;178:176–185. doi:10.1016/j.ajo.2017.03.029. [published Online First: Epub Date]|.
  • Ang M, Vasconcelos-Santos DV, Sharma K, et al. Diagnosis of ocular tuberculosis. Ocul Immunol Inflamm. 2018;26(2):208–216. doi:10.1080/09273948.2016.1178304. Epub 2016 Jul 5.[published Online First: Epub Date]|.
  • Lee C, Agrawal R, Pavesio C. Ocular tuberculosis–a clinical conundrum. Ocul Immunol Inflamm. 2016;24(2):237–242. doi:10.3109/09273948.2014.985387. Epub 2015 Jun 25.[published Online First: Epub Date]|.
  • Agrawal R, Testi I, Mahajan S, et al. Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis. Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.01.008. [published Online First: Epub Date]|.
  • Lou SM, Montgomery PA, Larkin KL, Winthrop K, Zierhut M, Rosenbaum JT. Diagnosis and treatment for ocular tuberculosis among uveitis specialists: the international perspective. Ocul Immunol Inflamm. 2015;23(1):32–39. doi:10.3109/09273948.2014.994784. [published Online First: Epub Date]|.
  • Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547–1567. doi:10.1111/jam.14478. [published Online First: Epub Date]|.
  • Agrawal R, Testi I, Bodaghi B, et al. Collaborative ocular tuberculosis study (COTS) consensus guidelines on the management of tubercular uveitis - report 2: guidelines for initiating anti-tubercular therapy in anterior uveitis, intermediate uveitis, panuveitis and retinal vasculitis. Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.06.052. [published Online First: Epub Date]|.
  • Standardization of Uveitis Nomenclature (SUN) Working Group Classification criteria for tubercular uveitis. Am J Ophthalmol. 2021;228:142–151. doi:10.1016/j.ajo.2021.03.040. [published Online First: Epub Date]|.
  • Standardization of Uveitis Nomenclature (SUN) Working Group Development of classification criteria for the uveitides. Am J Ophthalmol. 2021;228:96–105. doi:10.1016/j.ajo.2021.03.061. [published Online First: Epub Date]|.
  • Agrawal R, Testi I, Bodaghi B, et al. Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis. Ophthalmology. 2021;128(2):277–287. doi:10.1016/j.ophtha.2020.06.052. [published Online First: Epub Date]|.
  • Ting DSW, Pasquale LR, Peng L, et al. Artificial intelligence and deep learning in ophthalmology. Br J Ophthalmol. 2019;103(2):167–175. doi:10.1136/bjophthalmol-2018-313173. [published Online First: Epub Date]|.
  • Aslam B, Basit M, Nisar MA, Khurshid M, Rasool MH. Proteomics: technologies and their applications. J Chromatogr Sci. 2017;55(2):182–196. doi:10.1093/chromsci/bmw167. Epub 2016 Oct 18.[published Online First: Epub Date]|.
  • Penn-Nicholson A, Hraha T, Thompson EG, et al. Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study. PLoS Med. 2019;16(4):e1002781. doi:10.1371/journal.pmed.1002781. eCollection 2019 Apr.[published Online First: Epub Date]|.
  • Bansal R, Khan MM, Dasari S, et al. Proteomic profile of vitreous in patients with tubercular uveitis. Tuberculosis (Edinb). 2021;126:102036. doi:10.1016/j.tube.2020.102036. [published Online First: Epub Date]|.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.